"We look forward to bringing high-wage, advanced manufacturing, engineering and science jobs to people in Wisconsin, a state that is becoming a critical geography in our global manufacturing operations." Wisconsin Governor Tony Evers added, "As a US regional tech hub, Wisconsin is a national leader in personalized medicine and biohealth, and through this partnership with Lilly, we're going to keep advancing research and innovation and bolstering Wisconsin's manufacturing industry, all while supporting workers, families, and patients across our state and around the world." Eli Lilly is the maker of GLP-1 drugs Mounjaro and Zepbound, which are both forms of injectable tirzepatide used to treat type 2 diabetes and obesity
Inflammation in obesity-related HFpEF: The STEP-HFpEF Program
Side effects Common side effects Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Injection site reactions Other potential side effects: Indigestion Dizziness Back pain Increased lipase or amylase Altered taste Nasopharyngitis (common cold) Passing gas Bloating Belching Gastroenteritis Decreased appetite Gastroesophageal reflux disease Upset stomach These symptoms often subside as your body adjusts to the medications
The launch underscores Coupangs role as a bridge between innovative U.S
Nature 302, 716718
While much research has focused on the activation of stress response pathways during metabolic challenge, the mechanisms by which these pathways are attenuated once the stress subsides remain largely unexplored